Raymond James & Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.55M Sell
60,535
-21,876
-27% -$560K ﹤0.01% 2390
2024
Q2
$1.93M Sell
82,411
-32,104
-28% -$754K ﹤0.01% 2184
2024
Q1
$3.29M Sell
114,515
-4,666
-4% -$134K ﹤0.01% 1851
2023
Q4
$3.91M Sell
119,181
-12,172
-9% -$399K ﹤0.01% 1688
2023
Q3
$3.66M Sell
131,353
-6,054
-4% -$169K ﹤0.01% 1648
2023
Q2
$4.68M Buy
137,407
+2,948
+2% +$100K ﹤0.01% 1519
2023
Q1
$4.04M Sell
134,459
-13,222
-9% -$398K ﹤0.01% 1607
2022
Q4
$4.17M Sell
147,681
-57,686
-28% -$1.63M ﹤0.01% 1524
2022
Q3
$6.75M Buy
205,367
+33,730
+20% +$1.11M 0.01% 1174
2022
Q2
$5.41M Sell
171,637
-2,887
-2% -$90.9K 0.01% 1349
2022
Q1
$8.02M Sell
174,524
-46,671
-21% -$2.14M 0.01% 1199
2021
Q4
$13.5M Sell
221,195
-42,799
-16% -$2.62M 0.01% 941
2021
Q3
$19.7M Sell
263,994
-32,120
-11% -$2.4M 0.02% 715
2021
Q2
$27.4M Buy
296,114
+22,443
+8% +$2.08M 0.02% 557
2021
Q1
$24.3M Sell
273,671
-38,540
-12% -$3.42M 0.02% 576
2020
Q4
$29.1M Buy
312,211
+4,895
+2% +$457K 0.03% 461
2020
Q3
$19.6M Buy
307,316
+98,749
+47% +$6.29M 0.02% 547
2020
Q2
$10.9M Buy
208,567
+109,082
+110% +$5.69M 0.01% 783
2020
Q1
$3.11M Sell
99,485
-4,683
-4% -$146K ﹤0.01% 1316
2019
Q4
$3.49M Sell
104,168
-108,143
-51% -$3.63M ﹤0.01% 1491
2019
Q3
$6.27M Buy
212,311
+124,696
+142% +$3.68M 0.01% 1104
2019
Q2
$3.02M Buy
87,615
+21,514
+33% +$742K ﹤0.01% 1537
2019
Q1
$2.17M Buy
66,101
+25,628
+63% +$842K ﹤0.01% 1710
2018
Q4
$971K Sell
40,473
-5,962
-13% -$143K ﹤0.01% 2110
2018
Q3
$1.55M Buy
46,435
+25,193
+119% +$842K ﹤0.01% 1959
2018
Q2
$617K Buy
21,242
+5,312
+33% +$154K ﹤0.01% 2533
2018
Q1
$410K Buy
+15,930
New +$410K ﹤0.01% 2683